The impact of lipid-lowering medications on coronary artery plaque characteristics

Atherosclerosis is the predominant cause of coronary artery disease. The last several decades have witnessed significant advances in lipid-lowering therapies, which comprise a central component of atherosclerotic cardiovascular disease prevention. In addition to cardiovascular risk reduction with dy...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Vishnu Priya Pulipati, Francis J. Alenghat
Format: article
Langue:EN
Publié: Elsevier 2021
Sujets:
Accès en ligne:https://doaj.org/article/7f0b4c91947a49e98adcdcd27ed300e5
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!